Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection

JM Connors, RAS Ariëns - Journal of Thrombosis and Haemostasis, 2023 - Elsevier
Three years after the start of the pandemic, approaches to the prevention and treatment of
acute Covid-19 have been established. However, post-acute sequelae of SARS-CoV-2 …

[PDF][PDF] Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)

АН Плутницкий - 2022 - pharmedu.ru
В конце 2019 г. в Китайской Народной Республике (КНР) произошла вспышка новой
коронавирусной инфекции с эпицентром в городе Ухань (провинция Хубэй). Всемирная …

A Contemporary Review of Antiplatelet Therapies in Current Clinical Practice

S Arockiam, B Staniforth, S Kepreotis… - International Journal of …, 2023 - mdpi.com
Antiplatelet therapy plays a crucial role in a number of cardiovascular disorders. We
currently have a range of antiplatelet agents in our armamentarium. In this review, we aim to …

Microvascular thrombosis as a critical factor in severe COVID-19

PP Wadowski, B Panzer, A Józkowicz… - International Journal of …, 2023 - mdpi.com
Platelet–endothelial interactions have a critical role in microcirculatory function, which
maintains tissue homeostasis. The subtle equilibrium between platelets and the vessel wall …

Effects of standard-dose prophylactic, high-dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID …

V Labbé, D Contou, N Heming… - JAMA internal …, 2023 - jamanetwork.com
Importance Given the high risk of thrombosis and anticoagulation-related bleeding in
patients with hypoxemic COVID-19 pneumonia, identifying the lowest effective dose of …

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial

JS Berger, MD Neal, LZ Kornblith, MN Gong… - JAMA network …, 2023 - jamanetwork.com
Importance Platelet activation is a potential therapeutic target in patients with COVID-19.
Objective To evaluate the effect of P2Y12 inhibition among critically ill patients hospitalized …

[HTML][HTML] 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19

S Schulman, DM Arnold, CA Bradbury… - Journal of thrombosis …, 2024 - Elsevier
Based on emerging evidence from the COVID-19 pandemic, the International Society on
Thrombosis and Haemostasis (ISTH) guidelines for antithrombotic treatment in COVID-19 …

The COVID-19 pandemic and coronary heart disease: the next surge

A Shaikh, SD Khan, F Baloch, SS Virani… - Current Atherosclerosis …, 2023 - Springer
Abstract Purpose of Review In this narrative review, we highlight different ways in which the
COVID-19 pandemic has impacted coronary heart disease (CHD) burden and how a surge …

Antithrombotic therapy in arterial thrombosis and thromboembolism in COVID-19: an American College of Chest Physicians Expert Panel Report

T Potpara, DJ Angiolillo, B Bikdeli, D Capodanno… - Chest, 2023 - Elsevier
Background Evidence increasingly shows that the risk of thrombotic complications in COVID-
19 is associated with a hypercoagulable state. Several organizations have released …

Interaction of COVID-19 With Common Cardiovascular Disorders

PK Boulos, SV Freeman, TD Henry, E Mahmud… - Circulation …, 2023 - Am Heart Assoc
The onset and widespread dissemination of the severe acute respiratory syndrome
coronavirus-2 in late 2019 impacted the world in a way not seen since the 1918 H1N1 …